Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics
2013 · External reference
Unresolved reference
2008 · External reference
Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4 -STAT3 signaling
10.1158/0008-5472.can-12-3228 · 2013 · External reference
M2-polarized tumor-associated macrophages promoted epithelial- mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
10.1038/labinvest.2013.69 · 2013 · External reference
Anti-tumor strategies aiming to target tumor-associated macrophages
10.1111/imm.12023 · 2013 · External reference
Anti-inflammatory action of glucocorticoids–new mechanisms for old drugs
10.1056/nejmra050541 · 2005 · External reference
Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice
10.1593/neo.04340 · 2005 · External reference
Turmeric and cancer: an “old-age” disease with an “age-old” solution
10.1016/j.canlet.2008.03.025 · 2008 · External reference
Co-delivery of Turmeric and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with prostate cancer
2013 · External reference
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
10.1016/j.jconrel.2011.09.063 · 2012 · External reference
Pegylated liposomal doxorubicin: a guide to its use in various malignancies
10.1007/s40259-013-0070-1 · 2013 · External reference
A phase II study of caelyx (liposomal doxorubicin) in metastatic carcinoma of the prostate: tolerability and efficacy modification by liposomal encapsulation
10.1023/a:1016225024121 · 2002 · External reference
Liposomal nanomedicines in the treatment of prostate cancer
10.1016/j.ctrv.2013.10.005 · 2014 · External reference
Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes
10.1002/art.11140 · 2003 · External reference
Utility of targeted glucocorticoids in cancer therapy
10.1080/08982100801893978 · 2008 · External reference
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
2015 · External reference
Nuclear factor-kappaB: the enemy within
2004 · External reference
Multi-edged sword against cancer: ancient exotic spice
2014 · External reference
Anti-cancer effects of Turmeric: cycle of life and death
2014 · External reference
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
10.1016/0005-2736(91)90246-5 · 1991 · External reference
Liposomes: Technologies and analytical applications. Annu
10.1146/annurev.anchem.1.031207.112747 · 2008 · External reference
GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview
2018 · External reference
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
10.1186/1476-4598-6-24 · 2007 · External reference
Turmeric inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell prostate cancer cells
10.1016/j.bbrc.2005.06.093 · 2005 · External reference
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer
1999 · External reference
Long Noncoding RNAs as Biomarkers in Cancer
2018 · External reference
Improved vectors and genome-wide libraries for CRISPR screening
10.1038/nmeth.3047 · 2014 · External reference
Unresolved reference
1996 · External reference
andMuise-Helmericks, R. C. VEGF stimulation of mitochondrial biogenesis: requirement of Akt3 kinase
10.1096/fj.08-106468 · 2008 · External reference
Akt/PKB signaling in cancer: a function in cell motility and invasion
10.4161/cc.5.6.2561 · 2006 · External reference
The PTEN/PI3K/Akt signaling pathway in cancer, therapeutic implications
10.2174/156800908784293659 · 2008 · External reference
Advances of Akt pathway in human oncogenesis and as a target for anti-cancer drug discovery
10.2174/156800908783497159 · 2008 · External reference
Essential role of protein kinase Bγ (PKBγ/Akt3) in postnatal brain development but not in glucose homeostasis
10.1242/dev.01864 · 2005 · External reference
Role of PI3K/Akt/mTOR signaling in the cell cycle progression of human prostate cancer
10.1016/j.bbrc.2003.09.132 · 2003 · External reference
Interleukin-6 activatesPI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
10.1002/ijc.23261 · 2008 · External reference
β-Catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells
2003 · External reference
Tuning cell cycle regulation with aniron key
10.4161/cc.6.16.4603 · 2007 · External reference
CRISPR/Cas9 for genome editing: progress, implications and challenges
10.1093/hmg/ddu125 · 2014 · External reference
Development and applications of CRISPR-Cas9 for genome engineering
10.1016/j.cell.2014.05.010 · 2014 · External reference
CRISPR–Cas9 ERβ deletion reveals roles in prostate
10.1038/s41585-020-0302-3 · 2020 · External reference
MicroRNA expression profiling in prostate cancer
10.1158/0008-5472.can-07-0533 · 2007 · External reference
Micro RNAs in Cancer
10.1146/annurev.med.59.053006.104707 · 2009 · External reference
Micro RNAs: genomics, biogenesis, mechanism, and function
2004 · External reference
The potential of micro RNAs as human prostate cancer biomarkers: A meta-analysis of related studies
10.1002/jcb.26445 · 2018 · External reference
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage prostate cancer
10.1002/emmm.201100154 · 2011 · External reference
New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression
10.1371/journal.pone.0004995 · 2009 · External reference
PCA3 in the detection and management of early prostate cancer
10.1007/s13277-013-0739-6 · 2013 · External reference
Turmeric induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia
10.1016/j.bbrc.2005.12.014 · 2006 · External reference
Intratumoral immune landscape: immunogenicity to tolerogenicity
2015 · External reference
Multifocal signal modulation therapy of cancer: ancient weapon, modern targets
10.1007/s11010-009-0269-0 · 2010 · External reference
Turmeric and tumor immune-editing: resurrecting the immune system
10.1186/s13008-015-0012-z · 2015 · External reference
Turmeric mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer
10.1093/carcin/bgv006 · 2015 · External reference
Death by design: where Turmeric sensitizes drug-resistant tumors
2012 · External reference
Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3- (4-methoxyphenyl)-1H-indole-2-carboxylate
10.1186/1556-276x-6-482 · 2011 · External reference
Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery
2009 · External reference
Nanoliposome Potentials in Nanotherapy: A Concise Overview. Int
2010 · External reference
Nanoliposomes and their applications in food nanotechnology
10.1080/08982100802465941 · 2008 · External reference
Marinosomes, marine lipid-based liposomes: physical characterization and potential application in cosmetics
10.1016/s0378-5173(02)00217-x · 2002 · External reference
Liposomal curcumin and its application in cancer
10.2147/ijn.s132434 · 2017 · External reference
Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
2018 · External reference
